Добавил:
akasagenerdew@gmail.com Рязанский государственный медицинский университет - Студент Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

MSC - F. Surgery Answers 2025

.pdf
Скачиваний:
0
Добавлен:
12.09.2025
Размер:
3.67 Mб
Скачать

Intestinal:

o Strictures → obstruction

o Fistulas (e.g., entero-enteric, entero-vesical, entero-cutaneous)

o

Perforation

o

Malabsorption (esp. B12, bile salts)

oColorectal cancer (especially with colonic involvement)

Extraintestinal:

oJoint, skin, eye, and liver involvement

General:

oGrowth retardation (in children)

o Nutritional deficiencies

Diagnosis

1.Laboratory:

↑ CRP, ESR

Anemia (iron deficiency or chronic disease)

Hypoalbuminemia

Vitamin and mineral deficiencies

2.Stool studies:

Rule out infectious causes (e.g., C. difficile, parasites)

Fecal calprotectin: sensitive marker of intestinal inflammation

3.Imaging and endoscopy:

Colonoscopy with biopsy (gold standard): reveals skip lesions, cobblestone mucosa, aphthous ulcers

Histology: Transmural inflammation, granulomas (non-caseating)

MRI enterography/CT enterography: Useful for small bowel involvement, strictures, abscesses

Barium studies (e.g., small bowel follow-through): string sign, segmental narrowing

4.Other:

Capsule endoscopy (useful but avoid if strictures are suspected)

5.Crohn's disease: conservative treatment and surgical treatment.

Conservative (Medical) Treatment

A step-up approach is used based on severity.

1.Induction of Remission:

Mild-Moderate:

o Aminosalicylates (5-ASA): limited efficacy; not first-line

oBudesonide: for ileocecal disease

Moderate-Severe:

oSystemic corticosteroids: Prednisolone 40–60 mg/day

o Immunomodulators: Azathioprine, 6-mercaptopurine, methotrexate

oBiologics:

Anti-TNF: infliximab, adalimumab

Anti-integrin: vedolizumab

Anti-IL-12/23: ustekinumab

Antibiotics:

oMetronidazole, ciprofloxacin for perianal disease, abscesses, fistulas

Nutritional therapy:

oElemental diets, parenteral nutrition in severe cases

o Micronutrient supplementation: B12, folate, vitamin D, iron

Maintenance of Remission

Immunomodulators: azathioprine, methotrexate

Biologics (for those with moderate-severe disease or steroiddependent/refractory disease)

Smoking cessation is critical to reduce relapse

Surgical Treatment

Reserved for complications or medical failure. Not curative, unlike UC.

Absolute Indications:

1.Obstruction (due to strictures)

2.Fistulas, especially when complex and unresponsive to medical therapy

3.Perforation

4.Abscess formation

5.Refractory hemorrhage

6.Malignancy

Relative Indications:

Intractable symptoms despite optimal medical therapy

Growth failure in children

Severe perianal disease

Surgical Options:

Segmental bowel resection (avoid extensive resections; aim to preserve bowel length)

Strictureplasty (to relieve obstruction while preserving intestine)

Seton placement and drainage for perianal fistulas

Abscess drainage

Prognosis

Chronic disease with relapsing-remitting course

High recurrence rate after surgery (~30–50% at 5 years)

Higher morbidity than UC; mortality ~2× that of general population

Requires long-term multidisciplinary care

6.Differential diagnosis of ulcerative colitis and Crohn's disease.

Feature

Location

Ulcerative Colitis (UC)

Crohn's Disease (CD)

 

 

 

 

 

Can affect any part of GI tract

Limited to colon and always

from mouth to anus; most

involves the rectum

commonly terminal ileum &

 

colon

 

 

Pattern of involvement

Depth of inflammation

Rectal involvement

Anal involvement

Granulomas (on histology)

Ulcers

Strictures

Continuous involvement (starting at rectum)

Mucosal and submucosal only

Always involved

Rare

Absent

Superficial, broad-based ulcers

Uncommon

Segmental/skip lesions — patchy areas with intervening normal mucosa

Transmural (entire wall thickness)

Often spared

Common — fissures, fistulas, skin tags, abscesses

Non-caseating granulomas present in ~50%

Deep, linear ulcers — may lead to “cobblestone” mucosa

Common, due to transmural fibrosis

Feature

Fistulas and abscesses

Toxic megacolon

Bleeding

Diarrhea

Abdominal pain

Malabsorption

Weight loss

Extraintestinal manifestations

Cancer risk

Smoking

Surgical treatment

Endoscopic findings

Radiology (Barium studies)

Ulcerative Colitis (UC)

Rare

More common

Frequent, often with bloody diarrhea

Bloody, frequent, urgent

Usually LLQ, cramping, relieved by defecation

Rare

Less common or mild

Common in both: arthritis, uveitis, erythema nodosum, PSC more common in UC

↑ Colorectal cancer risk with long-standing disease

Crohn's Disease (CD)

Common (e.g., enteroenteric, perianal)

Rare

Less common; if present, mild

Variable, often non-bloody, chronic

Often RLQ, cramping, chronic

Common, esp. if small intestine involved (e.g., B12, iron, fatsoluble vitamins)

Common and may be severe

Similar, but more nutrient- deficiency–related complications

↑ Colorectal cancer if colon is involved

Protective

Colectomy is curative

Continuous erythema, loss of vascular pattern, friability, pseudopolyps

Lead pipe colon (loss of haustra)

Risk factor — worsens disease

Not curative, disease often recurs at anastomosis site

Patchy inflammation, aphthous ulcers, cobblestoning, strictures

String sign of terminal ileum, fistulas, strictures

 

 

 

 

Feature

 

Ulcerative Colitis (UC)

Crohn's Disease (CD)

 

 

 

 

 

 

 

 

ASCA/ANCA

 

p-ANCA: Positive in ~70%

ASCA: Positive in ~60%

serology

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mnemonic Tip:

UC = ULCCCERS o Ulcers

o Large intestine o Continuous

o Colorectal carcinoma risk o Crypt abscesses

o Extraintestinal manifestations o Rectal involvement

o Sclerosing cholangitis

Crohn’s = FISTULAS

o Fistulas

o Ilial involvement

o Skip lesions

o Transmural

o Ulcers (deep, linear)

o Luminal narrowing

o Anal lesions

o Strictures

Thoracic surgery

1.Acute lung abscess. Etiology, clinic, diagnosis, treatment.

Acute lung abscess is a localized suppurative (pus-forming) necrosis of lung parenchyma, characterized by one or more cavities filled with pus and gas, surrounded by inflammatory infiltration (perifocal inflammation).

Gangrenous abscess involves putrid suppurative decay with sequestra (dead lung tissue fragments) and significant perifocal inflammation.

Pulmonary gangrene is extensive putrid necrosis of a lung lobe or more, without demarcation, accompanied by severe systemic intoxication.

Etiology and Pathogenesis

The development of a lung abscess depends on several predisposing factors:

1. Presence of causative infectious agent:

oMainly Staphylococcus aureus and anaerobic bacteria play a major role.

2.Impaired bronchial drainage:

oObstruction leads to retention of secretions and predisposes to infection.

3.Impaired lung perfusion:

oVascular compromise promotes necrosis.

4.Reduced systemic and local immunity:

oConditions lowering host defenses, including malnutrition, immunosuppression, or chronic illness.

Common causes:

About 70% of acute lung abscesses develop as complications of acute pneumonia (commonly croupous or viral pneumonias).

Aspiration abscesses occur in patients with impaired consciousness or swallowing reflex, often localizing in posterior segments of the right lung.

Less common causes include septic emboli (from endocarditis, thrombophlebitis, osteomyelitis), chest trauma (penetrating or blunt), and rare lymphogenic spread.

Pathogenesis (example of postpneumonic abscess):

Infection activates inflammation, leading to bronchial edema, spasm, and obstruction → distal atelectasis → impaired circulation → necrosis → liquefaction and pus formation → abscess cavity formation.

Clinical Manifestations

Two clinical periods:

1. Closed period (before abscess rupture):

o Pleuritic chest pain localized to affected side, worsened by inspiration.

o Dry cough or scant sputum.

o High fever with hectic pattern, systemic intoxication.

o Dyspnea and decreased chest wall movement on affected side.

oPhysical exam: diminished breath sounds, dull percussion over inflamed area.

2.Open period (after abscess rupture into bronchus):

oExpectoration of large amounts of foul-smelling sputum (putrid or

“meat water” in gangrenous abscess).

o Decreased fever and systemic symptoms due to drainage.

o Possible hemoptysis.

oPhysical signs: tympanic percussion if near surface, bronchial breath sounds, rhonchi.

o If drainage is inadequate, fever and intoxication persist.

Pulmonary gangrene:

Severe systemic symptoms, cyanosis, marked dyspnea.

Large volumes of foamy, fetid sputum with blood.

Extensive dullness on percussion, diminished breath sounds, multiple moist crackles.

Diagnosis

Based on history (prior pneumonia, risk factors), clinical exam, and imaging.

Chest X-ray:

o Early stage: homogenous infiltrate without clear cavity.

o Later: cavitary lesion(s) with air-fluid levels.

oGangrene: large homogenous opacity expanding over a lobe or more, evolving into multiple cavitations.

Laboratory:

oLeukocytosis with neutrophilia, elevated ESR.

Differential diagnosis:

oSuppurated congenital cyst, tuberculous cavities, necrotic lung cancer.

Complications:

oPeripheral abscess → pneumothorax (11-39%).

o Central abscess → pulmonary hemorrhage (main cause of death).

Treatment

Conservative treatment is mainstay, consisting of:

1. Adequate drainage of pus:

oPromote bronchial drainage via postural drainage, inhalations, intratracheal administration of antiseptics, bronchodilators, antibiotics, and proteolytic enzymes.

oIn case of blocked drainage: thoracentesis and abscessoscopy to remove necrotic tissue.

2.Antibacterial therapy:

oEmpirical broad-spectrum antibiotics targeting anaerobes and staphylococci until culture results available.

oCommonly combinations of beta-lactams with metronidazole or clindamycin.

3.De-intoxication therapy:

oFluid resuscitation, plasma or plasma substitutes (albumin, amino acids).

oSupportive care to mitigate systemic effects of sepsis.

4.Immune correction:

oUse of bacteriophages (especially antistaphylococcal), immunoglobulins, and immunomodulators (gammaglobulin, decaris, T-activin).

Surgical treatment:

Reserved for complicated cases or non-responders to conservative therapy.

Indications include progressing gangrene, massive hemoptysis, or failure to resolve abscess.

Procedures include segmentectomy, lobectomy, or pneumonectomy depending on extent.

High mortality rate associated with surgery due to severity of disease.

In total lung gangrene with empyema, advanced techniques like splitsternum transpericardial bandaging of vessels and bronchus may be performed.

2.Complications of acute lung abscess. Causes of the transfer of acute lung abscess to chronic. Clinic, diagnosis, treatment of chronic lung abscess

Complications of Acute Lung Abscess

Empyema (pleural infection)

Pneumothorax and bronchopleural fistula

Sepsis and septicemia